A new gene test may spare thousands of women with a common type of breast tumor from unnecessary radiation, according to a study released today at the San Antonio Breast Cancer Symposium .
The test, which analyzes 12 genes from a woman's tumor, helps predict which cases are most likely to be aggressive — requiring both surgery and radiation — and which are likely to be slow-growing, requiring surgery alone, says lead researcher Lawrence Solin, chairman of radiation oncology at Einstein Medical Center in Philadelphia.
"This is a perfect example of
how understanding the human genome can be translated into real life, to
help real women," Solin says. "This is a very exciting advance." Read More